IdentifAI

Tel Aviv, Israel Founded: 2020 • Age: 6 yrs
Non-invasive prenatal screening for genetic syndromes is provided.
Request Access

About IdentifAI

IdentifAI is a company based in Tel Aviv (Israel) founded in 2020 by Tom Rabinowitz, Amir Beker, Oren Tadmor, Yossi Bornstein, and Noam Shomron.. IdentifAI has raised $9.8 million across 3 funding rounds from investors including Shizim, unknown and eHealth Ventures. IdentifAI offers products and services including Prenatal Genetic Screening Test. IdentifAI operates in a competitive market with competitors including Natera, Progenity, SYNLAB, Beikang Medical and Yourgene Health, among others.

  • Headquarter Tel Aviv, Israel
  • Founders Tom Rabinowitz, Amir Beker, Oren Tadmor, Yossi Bornstein, Noam Shomron
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $9.8 M (USD)

    in 3 rounds

  • Latest Funding Round
    $6.5 M (USD), Series A

    Dec 08, 2024

  • Investors
    Shizim

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of IdentifAI

IdentifAI offers a comprehensive portfolio of products and services, including Prenatal Genetic Screening Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Non-invasive blood test for early detection of fetal genetic disorders.

Funding Insights of IdentifAI

IdentifAI has successfully raised a total of $9.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $6.5 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $6.5M
  • First Round

    (18 Mar 2023)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2024 Amount Grant - IdentifAI Valuation

investors

Dec, 2024 Amount Series A - IdentifAI Valuation

investors

Mar, 2023 Amount Seed - IdentifAI Valuation eHealth Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in IdentifAI

IdentifAI has secured backing from 4 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Shizim, unknown and eHealth Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Early-stage digital health ventures are funded and supported.
Founded Year Domain Location

Ron Sabar

-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by IdentifAI

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - IdentifAI

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Identifai Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of IdentifAI

IdentifAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Progenity, SYNLAB, Beikang Medical and Yourgene Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Non-invasive prenatal genomic testing is provided for genetic disorders.
domain founded_year HQ Location
Provider of medical diagnosis and clinical laboratory analysis services
domain founded_year HQ Location
NGS-based diagnostic solutions for neonatal screening are developed.
domain founded_year HQ Location
Non-invasive prenatal genetic tests and genomic services are provided.
domain founded_year HQ Location
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Identifai

Frequently Asked Questions about IdentifAI

When was IdentifAI founded?

IdentifAI was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Where is IdentifAI located?

IdentifAI is headquartered in Tel Aviv, Israel.

Who is the current CEO of IdentifAI?

Amir Beker is the current CEO of IdentifAI. They have also founded this company.

Is IdentifAI a funded company?

IdentifAI is a funded company, having raised a total of $9.8M across 3 funding rounds to date. The company's 1st funding round was a Seed of $3.3M, raised on Mar 18, 2023.

What does IdentifAI do?

IdentifAI was established in 2020 in Tel Aviv, Israel, within the biotechnology sector. Focus is placed on prenatal diagnostics through a non-invasive test that detects genetic syndromes. Proprietary algorithms in data science and bioinformatics are employed to assess fetal health during early pregnancy stages. Operations center on delivering accessible screening options for expectant parents in the region.

Who are the top competitors of IdentifAI?

IdentifAI's top competitors include Natera, SYNLAB and Beikang Medical.

What products or services does IdentifAI offer?

IdentifAI offers Prenatal Genetic Screening Test.

Who are IdentifAI's investors?

IdentifAI has 4 investors. Key investors include Shizim, unknown, eHealth Ventures, and Ron Sabar.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available